Clinical mitochondrial genetics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 10874629.
- Also identified by PMC identifier 1734386.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The last decade has been an age of enlightenment as far as mitochondrial pathology is concerned. Well established nuclear genetic diseases, such as Friedreich's ataxia,<sup>12</sup> Wilson disease,<sup>3</sup> and autosomal recessive hereditary spastic paraplegia,<sup>4</sup> have been shown to have a mitochondrial basis, and we are just starting to unravel the complex nuclear genetic disorders which directly cause mitochondrial dysfunction (table 1). However, in addition to the 3 billion base pair nuclear genome, each human cell typically contains thousands of copies of a small, 16.5 kb circular molecule of double stranded DNA (fig 1). Mitochondrial DNA (mtDNA) accounts for only 1% of the total cellular nucleic acid content. It encodes for 13 polypeptides which are essential for aerobic metabolism and defects of the mitochondrial genome are an important cause of human disease.<sup>9293</sup> Since the characterisation of the first pathogenic mtDNA defects in 1988,<sup>513</sup> over 50 point mutations and well over 100 rearrangements of the mitochondrial genome have been associated with human disease<sup>9495</sup> (http://www.gen.emory.edu/mitomap.html). These disorders form the focus of this article. Keywords: mitochondrial DNA; mitochondrial disease; heteroplasmy; genetic counselling
Medical subject headings
- Mitochondria
- Mitochondrial Myopathies